High Level of CD8 + PD-1 + Cells in Patients with Chronic Myeloid Leukemia Who Experienced Loss of MMR after Imatinib Discontinuation
Kwaśnik, Paulina, Zaleska, Joanna, Link-Lenczowska, Dorota, Zawada, Magdalena, Wysogląd, Hubert, Ochrem, Bogdan, Bober, Grażyna, Wasilewska, Ewa, Hus, Iwona, Szarejko, Monika, Prejzner, Witold, Grzybowska-Izydorczyk, Olga, Klonowska-Szymczyk, Agnieszka, Mędraś, Ewa, Kiełbus, Michał, Sacha, Tomasz, Giannopoulos, Krzysztof
Published in Cells (Basel, Switzerland) (22.04.2024)
Published in Cells (Basel, Switzerland) (22.04.2024)
Get full text
Journal Article
A multicenter prospective study on efficacy and safety of imatinib generics: A report from Polish Adult Leukemia Group imatinib generics registry
Sacha, Tomasz, Góra‐Tybor, Joanna, Szarejko, Monika, Bober, Grażyna, Grzybowska‐Izydorczyk, Olga, Niesiobędzka‐Krężel, Joanna, Dudziński, Marek, Wasilewska, Ewa, Myśliwiec, Krzysztof, Gil, Justyna, Gniot, Michał, Pietkun, Iwona, Mędraś, Ewa, Hołojda, Jadwiga, Wącław, Joanna, Giannopoulos, Krzysztof
Published in American journal of hematology (01.07.2017)
Published in American journal of hematology (01.07.2017)
Get full text
Journal Article
Quality of Life and Adherence to Therapy in Patients With Chronic Myeloid Leukemia Treated With Nilotinib as a Second-Line Therapy: A Multicenter Prospective Observational Study
Sacha, Tomasz, Góra-Tybor, Joanna, Wąsak-Szulkowska, Ewa, Kyrcz-Krzemień, Sławomira, Mędraś, Ewa, Becht, Rafał, Bober, Grażyna, Kotowska, Aneta, Wącław, Joanna, Hellmann, Andrzej
Published in Clinical lymphoma, myeloma and leukemia (01.05.2017)
Published in Clinical lymphoma, myeloma and leukemia (01.05.2017)
Get full text
Journal Article
The Hasford Score May Predict Molecular Response in Chronic Myeloid Leukemia Patients: A Single Institution Experience
Kaczmar-Dybko, Agnieszka, Kuliczkowski, Kazimierz, Mędraś, Ewa, Lonc, Tomasz, Wróbel, Tomasz, Kapelko-Słowik, Katarzyna, Urbaniak-Kujda, Donata, Haus, Olga, Jaźwiec, Bożena, Dybko, Jarosław, Sawicki, Mateusz
Published in Disease markers (01.01.2016)
Published in Disease markers (01.01.2016)
Get full text
Journal Article
Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis: A Retrospective Analysis of 527 Patients From the Polish Adult Leukemia Group Registry
Gora-Tybor, Joanna, Sacha, Tomasz, Wącław, Joanna, Niesiobędzka-Krężel, Joanna, Grzybowska-Izydorczyk, Olga, Mędraś, Ewa, Dereń-Wagemann, Izabela, Patkowska, Elżbieta, Seferyńska, Ilona, Lewandowski, Krzysztof, Wache, Anna, Blajer-Olszewska, Beata, Wątek, Marzena, Kotwica-Mojzych, Katarzyna, Wasilewska, Ewa, Warzocha, Krzysztof, Jamroziak, Krzysztof
Published in Clinical lymphoma, myeloma and leukemia (01.07.2018)
Published in Clinical lymphoma, myeloma and leukemia (01.07.2018)
Get full text
Journal Article
Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis
Kantarjian, Hagop M., Hughes, Timothy P., Larson, Richard A., Kim, Dong-Wook, Issaragrisil, Surapol, le Coutre, Philipp, Etienne, Gabriel, Boquimpani, Carla, Pasquini, Ricardo, Clark, Richard E., Dubruille, Viviane, Flinn, Ian W., Kyrcz-Krzemien, Slawomira, Medras, Ewa, Zanichelli, Maria, Bendit, Israel, Cacciatore, Silvia, Titorenko, Ksenia, Aimone, Paola, Saglio, Giuseppe, Hochhaus, Andreas
Published in Leukemia (01.02.2021)
Published in Leukemia (01.02.2021)
Get full text
Journal Article
Imatinib Generics in Treatment of Chronic Myeloid Leukemia; A Prospective Observation in Large Cohort of Patients from Polish (PALG) Imatinib Generics Registry
Sacha, Tomasz, Gora-Tybor, Joanna, Szarejko, Monika, Bober, Grażyna, Grzybowska-Izydorczyk, Olga, Niesiobędzka-Krężel, Joanna, Dudziński, Marek, Wasilewska, Ewa, Myśliwiec, Krzysztof, Gil, Justyna, Gniot, Michał, Pietkun, Iwona, Mędraś, Ewa, Wącław, Joanna, Giannopoulos, Krzysztof
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Quality of life and adherence to therapy in patients with chronic myeloid leukemia treated with nilotinib as a second line therapy: a multicener prospective observational study
Sacha, Tomasz, Góra-Tybor, Joanna, Wąsak-Szulkowska, Ewa, Kyrcz-Krzemień, Sławomira, Mędraś, Ewa, Becht, Rafał, Bober, Grażyna, Kotowska, Aneta, Wącław, Joanna, Hellmann, Andrzej
Published in Clinical lymphoma, myeloma and leukemia (2017)
Published in Clinical lymphoma, myeloma and leukemia (2017)
Get full text
Journal Article
Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis
Kantarjian, Hagop M., Hughes, Timothy P., Larson, Richard A., Kim, Dong-Wook, Issaragrisil, Surapol, le Coutre, Philipp, Etienne, Gabriel, Boquimpani, Carla, Pasquini, Ricardo, Clark, Richard E., Dubruille, Viviane, Flinn, Ian W., Kyrcz-Krzemien, Slawomira, Medras, Ewa, Zanichelli, Maria, Bendit, Israel, Cacciatore, Silvia, Titorenko, Ksenia, Aimone, Paola, Saglio, Giuseppe, Hochhaus, Andreas
Published in Leukemia (01.07.2021)
Published in Leukemia (01.07.2021)
Get full text
Journal Article
A Multicenter Prospective Study on Efficacy and Safety of Ponatinib in Patients with Chronic Myeloid Leukemia Resistant or Intolerant to Previous Therapy: A 3-Year Report
Sacha, Tomasz, Szczepanek, Elzbieta, Dumnicka, Paulina, Gora-Tybor, Joanna, Niesiobedzka-Krezel, Joanna, Prejzner, Witold, Wasilewska, Ewa, Kloczko, Janusz, Ciepluch, Hanna, Makowska, Wioletta, Patkowska, Elzbieta, Wasilewska, Joanna, Bober, Grazyna, Kopera, Malgorzata, Wichary, Ryszard, Kroll-Balcerzak, Renata, Gromek, Tomasz, Wach, Malgorzata, Rudkowska-Kazanowska, Anna, Swiniarska, Magdalena, Paczkowska, Edyta, Medras, Ewa, Joks, Monika, Oller, Marta, Kasza, Renata, Kostyra, Aleksandra, Gil, Justyna, Grzybowska-Izydorczyk, Olga
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Real-life comparison of severe vascular events and other non-hematological complications in patients with chronic myeloid leukemia undergoing second-line nilotinib or dasatinib treatment
Gora-Tybor, Joanna, Medras, Ewa, Calbecka, Malgorzata, Kolkowska-Leśniak, Agnieszka, Ponikowska-Szyba, Edyta, Robak, Tadeusz, Jamroziak, Krzysztof
Published in Leukemia & lymphoma (03.08.2015)
Published in Leukemia & lymphoma (03.08.2015)
Get full text
Journal Article
Long-Term Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase Receiving Frontline Nilotinib Versus Imatinib: Enestnd 10-Year Analysis
Hughes, Timothy P., Saglio, Giuseppe, Larson, Richard A., Kantarjian, Hagop M., Kim, Dong-Wook, Issaragrisil, Surapol, Le Coutre, Philipp, Etienne, Gabriel, Boquimpani, Carla, Clark, Richard E., Dubruille, Viviane, Flinn, Ian W., Kyrcz-Krzemien, Slawomira, Medras, Ewa, Zanichelli, Maria, Bendit, Israel, Sondhi, Manu, Titorenko, Ksenia, Nourry-Boulot, Claire, Aimone, Paola, Hochhaus, Andreas
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
The Hasford Score Correlates with the Long-Term Molecular Response to Imatinib Treatment for Chronic Myeloid Leukemia Patients and May be Useful for Differentiating Low and Intermediate Risk Patients: A Single Institution Experience
Dybko, Jaroslaw, Medras, Ewa, Haus, Olga, Jazwiec, Bozena, Wrobel, Tomasz, Kuliczkowski, Kazimierz
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Concomitant Medications and Comorbidities Affect Early Response in CML Patients Treated with Imatinib: A Retrospective Analysis of 340 Patients from the Polish Adult Leukemia Group (PALG) Registry
Gora Tybor, Joanna, Sacha, Tomasz, Waclaw, Joanna, Niesiobedzka-Krezel, Joanna, Grzybowska-Izydorczyk, Olga, Medras, Ewa, Deren-Wagemann, Izabela, Patkowska, Elzbieta, Seferynska, Ilona, Lewandowski, Krzysztof, Wache, Anna, Blajer-Olszewska, Beata, Watek, Marzena, Wasilewska, Ewa, Stoklosa, Tomasz, Warzocha, Krzysztof, Jamroziak, Krzysztof
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Real-Life Comparison Of Severe Vascular Events and Other Non-Hematological Complications In CML Patients Treated With Second Line Nilotinib Or Dasatinib
Gora-Tybor, Joanna, Medras, Ewa, Calbecka, Malgorzata, Kolkowska, Agnieszka, Ponikowska-Szyba, Edyta, Robak, Tadeusz, Jamroziak, Krzysztof
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
CD117 (c-kit) Expression On CD34+ Cells Participates In The Cytogenetic Response To Imatinib In CML Patients In First Chronic Phase
Dybko, Jaroslaw, Medras, Ewa, Haus, Olga, Jazwiec, Bozena, Urbaniak, Joanna, Wozniak, Mieczyslaw, Kuliczkowski, Kazimierz
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis: A Retrospective Analysis of 470 Patients from the Polish Adult Leukemia Group (PALG) Registry
Gora-Tybor, Joanna, Sacha, Tomasz, Waclaw, Joanna, Niesiobedzka, Joanna, Grzybowska-Izydorczyk, Olga, Medras, Ewa, Deren-Wagemann, Izabela, Patkowska, Elzbieta, Seferynska, Ilona, Lewandowski, Krzysztof, Wache, Anna, Blajer-Olszewska, Beata, Watek, Marzena, Warzocha, Krzysztof, Jamroziak, Krzysztof
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Imatinib in Chronic Myeloid Leukemia - Five Years Single Center Experience
Dybko, Jaroslaw, Medras, Ewa, Bednarz, Renata, Urbaniak, Donata, Kuliczkowski, Kazimierz
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article